Coding and non-coding roles of MOCCI (C15ORF48) coordinate to regulate host inflammation and immunity
-
Published:2021-04-09
Issue:1
Volume:12
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Lee Cheryl Q. E., Kerouanton Baptiste, Chothani Sonia, Zhang Shan, Chen Ying, Mantri Chinmay KumarORCID, Hock Daniella HelenaORCID, Lim RadianceORCID, Nadkarni Rhea, Huynh Vinh Thang, Lim Daryl, Chew Wei LeongORCID, Zhong Franklin L.ORCID, Stroud David ArthurORCID, Schafer SebastianORCID, Tergaonkar Vinay, St John Ashley L.ORCID, Rackham Owen J. L.ORCID, Ho LenaORCID
Abstract
AbstractMito-SEPs are small open reading frame-encoded peptides that localize to the mitochondria to regulate metabolism. Motivated by an intriguing negative association between mito-SEPs and inflammation, here we screen for mito-SEPs that modify inflammatory outcomes and report a mito-SEP named “Modulator of cytochrome C oxidase during Inflammation” (MOCCI) that is upregulated during inflammation and infection to promote host-protective resolution. MOCCI, a paralog of the NDUFA4 subunit of cytochrome C oxidase (Complex IV), replaces NDUFA4 in Complex IV during inflammation to lower mitochondrial membrane potential and reduce ROS production, leading to cyto-protection and dampened immune response. The MOCCI transcript also generates miR-147b, which targets the NDUFA4 mRNA with similar immune dampening effects as MOCCI, but simultaneously enhances RIG-I/MDA-5-mediated viral immunity. Our work uncovers a dual-component pleiotropic regulation of host inflammation and immunity by MOCCI (C15ORF48) for safeguarding the host during infection and inflammation.
Funder
Howard Hughes Medical Institute National Research Fellowship Singapore
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference121 articles.
1. Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M. & Teixeira, M. M. Resolution of inflammation: what controls its onset? Front. Immunol. 7, 160 (2016). 2. Bäck, M., Yurdagul, A., Tabas, I., Öörni, K. & Kovanen, P. T. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-019-0169-2 (2019). 3. Mehta, M. M., Weinberg, S. E. & Chandel, N. S. Mitochondrial control of immunity: beyond ATP. Nat. Rev. Immunol. 17, 608–620 (2017). 4. Rimessi, A., Previati, M., Nigro, F., Wieckowski, M. R. & Pinton, P. Mitochondrial reactive oxygen species and inflammation: molecular mechanisms, diseases and promising therapies. Int. J. Biochem. Cell Biol. 81, 281–293 (2016). 5. Vazquez, C. & Horner, S. M. MAVS coordination of antiviral innate immunity. J. Virol. 89, 6974–6977 (2015).
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|